D. E. Shaw & Co., Inc. Biora Therapeutics, Inc. Transaction History

D. E. Shaw & Co., Inc.

$107 Billion
Q3 2024

Shares

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2022 May 16, 2022	SELL	$1.11 - $2.25 $292,317 - $592,535	-263,349 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$1.35 - $4.89 $355,521 - $1.29 Million	263,349 New	263,349 $550,000
Q3 2021 Nov 15, 2021	SELL	$0.67 - $3.41 $162,213 - $825,591	-242,109 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$2.11 - $4.93 $510,849 - $1.19 Million	242,109 New	242,109 $864,000
Q1 2021 May 17, 2021	SELL	$3.91 - $7.31 $172,778 - $323,021	-44,189 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$3.27 - $9.48 $144,498 - $418,911	44,189 New	44,189 $235,000

Others Institutions Holding BIOR

# of Institutions

2

Shares Held

890

Call Options Held

0

Put Options Held

0

About BIORA THERAPEUTICS, INC.

Ticker BIOR
Exchange NASDAQ
Shares Outstandng 186,623,605
Market Cap $312M
Description
Biora Therapeutics, Inc., a biotechnology company, engages in developing oral biotherapeutics. The company's targeted therapeutics program uses an ingestible smart capsule for targeted delivery of therapeutics in the gastrointestinal (GI) tract to enhance the treatment of inflammatory bowel diseases; and systemic therapeutics program uses an ing...

More about BIOR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.